GITR-GITRL system, a novel player in shock and inflammation

TheScientificWorldJournal

Volumn 7, Issue , 2007, Pages 533-566

  Krausz, Ludovic Tibor ^a   Bianchini, Rodolfo ^a   Ronchetti, Simona ^a   Fettucciari, Katia ^a   Nocentini, Giuseppe ^a   Riccardi, Carlo ^a  

^a NONE

Author keywords

Dendritic cells; Endothelial cells; Fusion proteins; Immune response; In vivo model; Inflammation; Innate immunity; Regulatory T cells; T cell modulation; T cells; Tumor necrosis factor receptor superfamily; Tumor necrosis factor superfamily

Indexed keywords

CD3 ANTIBODY; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEXAMETHASONE; GELATINASE A; GELATINASE B; GLUCOCORTICOID; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR ANTIBODY; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR FC; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR LIGAND; HISTAMINE; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; INTERCELLULAR ADHESION MOLECULE 1; LEUKOTRIENE; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROTEIN ARGININE METHYLTRANSFERASE; THROMBOCYTE ACTIVATING FACTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; NERVE GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ALTERNATIVE RNA SPLICING; ARTICLE; AUTOIMMUNITY; BLINDNESS; CD4+ CD25+ T LYMPHOCYTE; CELL DEATH; COLITIS; COMBINATION CHEMOTHERAPY; DENDRITIC CELL; EDEMA; EFFECTOR CELL; EXTRAVASATION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE; MONOTHERAPY; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; RNA SPLICING; SHOCK; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION; TREATMENT PLANNING; UPREGULATION; ANIMAL; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PROTEIN BINDING; REVIEW;

ANIMALS; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; HUMANS; INFLAMMATION; PROTEIN BINDING; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; SHOCK;

EID: 34247634525     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2007.106     Document Type: Article

References (125)

1. Nocentini, G., Giunchi, L., Ronchetti, S., Krausz, L.T., Bartoli, A., Moraca, R., Migliorati, G., and Riccardi, C. (1997) A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptorinduced apoptosis. Proceedings of the National Academy of Sciences of the United States of America 94, 6216-6221.
2. Kim, J.D., Choi, B.K., Bae, J.S., Lee, U.H., Han, I.S., Lee, H.W., Youn, B.S., Vinay, D.S., and Kwon, B.S. (2003) Cloning and characterization of GITR ligand. Genes Immun 4, 564-569.
3. Kwon, B., Yu, K.Y., Ni, J., Yu, G.L., Jang, I.K., Kim, Y.J., Xing, L., Liu, D., Wang, S.X., and Kwon, B.S. (1999) Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. The Journal of biological chemistry 274, 6056-6061.
4. Gurney, A.L., Marsters, S.A., Huang, R.M., Pitti, R.M., Mark, D.T., Baldwin, D.T., Gray, A.M., Dowd, A.D., Brush, A.D., Heldens, A.D., Schow, A.D., Goddard, A.D., Wood, W.I., Baker, K.P., Godowski, P.J., and Ashkenazi, A. (1999) Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr Biol 9, 215-218.
5. Yu, K.Y., Kim, H.S., Song, S.Y., Min, S.S., Jeong, J.J., and Youn, B.S. (2003) Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells. Biochem Biophys Res Commun 310, 433-438.
6. Ronchetti, S., Zollo, O., Bruscoli, S., Agostini, M., Bianchini, R., Nocentini, G., Ayroldi, E., and Riccardi, C. (2004) GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 34, 613-622.
7. Tone, M., Tone, Y., Adams, E., Yates, S.F., Frewin, M.R., Cobbold, S.P., and Waldmann, H. (2003) Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proceedings of the National Academy of Sciences of the United States of America 100, 15059-15064.
8. Bossen, C., Ingold, K., Tardivel, A., Bodmer, J.L., Gaide, O., Hertig, S., Ambrose, C., Tschopp, J., and Schneider, P. (2006) Interactions of Tumor Necrosis Factor (TNF) and TNF Receptor Family Members in the Mouse and Human. The Journal of biological chemistry 281, 13964-13971.
9. Nocentini, G., and Riccardi, C. (2005) GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol 35, 1016-1022.
10. Esparza, E.M., and Arch, R.H. (2006) Signaling triggered by glucocorticoid-induced tumor necrosis factor receptor family-related gene: regulation at the interface between regulatory T cells and immune effector cells. Front Biosci 11, 1448-1465.
11. Shevach, E.M., and Stephens, G.L. (2006) The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 6, 613-618.
12. Hanabuchi, S., Watanabe, N., Wang, Y.H., Wang, Y.H., Ito, T., Shaw, J., Cao, W., Qin, F.X., and Liu, Y.J. (2006) Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood 107, 3617-3623.
13. McHugh, R.S., Whitters, M.J., Piccirillo, C.A., Young, D.A., Shevach, E.M., Collins, M., and Byrne, M.C. (2002) CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311-323.
14. Kohm, A.P., Williams, J.S., and Miller, S.D. (2004) Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis. J Immunol 172, 4686-4690.
15. Kanamaru, F., Youngnak, P., Hashiguchi, M., Nishioka, T., Takahashi, T., Sakaguchi, S., Ishikawa, I., and Azuma, M. (2004) Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells. J Immunol 172, 7306-7314.
16. Stephens, G.L., McHugh, R.S., Whitters, M.J., Young, D.A., Luxenberg, D., Carreno, B.M., Collins, M., and Shevach, E.M. (2004) Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 173, 5008-5020.
17. Zelenika, D., Adams, E., Humm, S., Graca, L., Thompson, S., Cobbold, S.P., and Waldmann, H. (2002) Regulatory T cells overexpress a subset of Th2 gene transcripts. J. Immunol. 168, 1069-1079.
18. Uraushihara, K., Kanai, T., Ko, K., Totsuka, T., Makita, S., Iiyama, R., Nakamura, T., and Watanabe, M. (2003) Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells. 171, 708-716.
19. Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., and Sakaguchi, S. (2002) Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3, 135-142.
20. Scotto, L., Naiyer, A.J., Galluzzo, S., Rossi, P., Manavalan, J.S., Kim-Schulze, S., Fang, J., Favera, R.D., Cortesini, R., and Suciu-Foca, N. (2004) Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells. Hum Immunol 65, 1297-1306.
21. Cosmi, L., Liotta, F., Lazzeri, E., Francalanci, M., Angeli, R., Mazzinghi, B., Santarlasci, V., Manetti, R., Vanini, V., Romagnani, P., Maggi, E., Romagnani, S., and Annunziato, F. (2003) Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 102, 4107-4114.
22. Kim, H.J., Kim, H.Y., Kim, B.K., Kim, S., and Chung, D.H. (2006) Engagement of glucocorticoid-induced TNF receptor costimulates NKT cell activation in vitro and in vivo. J Immunol 176, 3507-3515.
23. Cuzzocrea, S., Nocentini, G., Di Paola, R., Agostini, M., Mazzon, E., Ronchetti, S., Crisafulli, C., Esposito, E., Caputi, A.P., and Riccardi, C. (2006) Proinflammatory role of glucocorticoid-induced TNF receptor-related gene in acute lung inflammation. J Immunol 177, 631-641.
24. Santucci, L., Agostini, M., Bruscoli, S., Mencarelli, A., Ronchetti, S., Ayroldi, E., Morelli, A., Baldoni, M., and Riccardi, C. (2007) GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut 56, 52-60.
25. Nakae, S., Suto, H., Iikura, M., Kakurai, M., Sedgwick, J.D., Tsai, M., and Galli, S.J. (2006) Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 176, 2238-2248.
26. Ronchetti, S., Nocentini, G., Riccardi, C., and Pandolfi, P.P. (2002) Role of GITR in activation response of T lymphocytes. Blood 100, 350-352.
27. Ji, H.B., Liao, G., Faubion, W.A., Abadia-Molina, A.C., Cozzo, C., Laroux, F.S., Caton, A., and Terhorst, C. (2004) Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol 172, 5823-5827.
28. Shin, H.H., Kim, S.G., Lee, M.H., Suh, J.H., Kwon, B.S., and Choi, H.S. (2003) Soluble glucocorticoid-induced TNF receptor (sGITR) induces inflammation in mice. Exp Mol Med 35, 358-364.
29. Shin, H.H., Kwon, B.S., and Choi, H.S. (2002) Recombinant glucocorticoid induced tumour necrosis factor receptor (rGITR) induced COX-2 activity in murine macrophage Raw 264.7 cells. Cytokine 19, 187-192.
30. Albers, A.E., Ferris, R.L., Kim, G.G., Chikamatsu, K., DeLeo, A.B., and Whiteside, T.L. (2005) Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites. Cancer Immunol Immunother 54, 1072-1081.
31. Wang, J., Devgan, V., Corrado, M., Prabhu, N.S., El-Deiry, W.S., Riccardi, C., Pandolfi, P.P., Missero, C., and Dotto, G.P. (2005) Glucocorticoid-induced tumor necrosis factor receptor is a p21Cip1/WAF1 transcriptional target conferring resistance of keratinocytes to UV light-induced apoptosis. The Journal of Biological Chemistry 280, 37725-37731.
32. Shin, H.H., Kim, S.J., Lee, D.S., and Choi, H.S. (2005) Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) stimulates osteoclast differentiation in response to receptor activator of NF-kappaB ligand (RANKL) in osteoclast cells. Bone 36, 832-839.
33. Kim, B.J., Li, Z., Fariss, R.N., Shen de, F., Mahesh, S.P., Egwuagu, C., Yu, C.R., Nagineni, C.N., Chan, C.C., and Nussenblatt, R.B. (2004) Constitutive and cytokine-induced GITR ligand expression on human retinal pigment epithelium and photoreceptors. Invest Ophthalmol Vis Sci 45, 3170-3176.
34. Boussaud, V., Soler, P., Moreau, J., Goodwin, R.G., and Hance, A.J. (1998) Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in human lung. Eur Respir J 12, 926-931.
35. Li, Z., Mahesh, S.P., Kim, B.J., Buggage, R.R., and Nussenblatt, R.B. (2003) Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. J Autoimmun 21, 83-92.
36. Zhang, X., Chen, Z., Huang, H., Gordon, J.R., and Xiang, J. (2002) DNA microarray analysis of the gene expression profiles of naive versus activated tumor-specific T cells. Life Sci 71, 3005-3017.
37. Siepmann, K., Biester, S., Plskova, J., Muckersie, E., Duncan, L., and Forrester, J.V. (2006) CD4(+)CD25 (+) T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo. Graefes Arch. Clin. Exp. Ophthalmol. 245, 221-229.
38. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155, 1151-1164.
39. Herman, A.E., Freeman, G.J., Mathis, D., and Benoist, C. (2004) CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. The Journal of Experimental Medicine 199, 1479-1489.
40. Levings, M.K., Sangregorio, R., Sartirana, C., Moschin, A.L., Battaglia, M., Orban, P.C., and Roncarolo, M.G. (2002) Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. The Journal of Experimental Medicine 196, 1335-1346.
41. Cobbold, S.P., Castejon, R., Adams, E., Zelenika, D., Graca, L., Humm, S., and Waldmann, H. (2004) Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 172, 6003-6010.
42. Heikkinen, J., Mottonen, M., Alanen, A., and Lassila, O. (2004) Phenotypic characterization of regulatory T cells in the human decidua. Clin. Exp. Immunol. 136, 373-378.
43. de Kleer, I.M., Wedderburn, L.R., Taams, L.S., Patel, A., Varsani, H., Klein, M., de Jager, W., Pugayung, G., Giannoni, F., Rijkers, G., Albani, S., Kuis, W., and Prakken, B. (2004) CD4+CD25bright regulatory T cells .actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. 172, 6435-6443.
44. Makita, S., Kanai, T., Oshima, S., Uraushihara, K., Totsuka, T., Sawada, T., Nakamura, T., Koganei, K., Fukushima, T., and Watanabe, M. (2004) CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 173, 3119-3130.
45. Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4, 330-336.
46. Chen, C., Rowell, E.A., Thomas, R.M., Hancock, W.W., and Wells, A.D. (2006) Transcriptional regulation by foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. The Journal of Biological Chemistry 281, 36828-36834.
47. Khattri, R., Cox, T., Yasayko, S.A., and Ramsdell, F. (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4, 337-342.
48. Hori, S., Nomura, T., and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061.
49. Veldman, C., Pahl, A., Beissert, S., Hansen, W., Buer, J., Dieckmann, D., Schuler, G., and Hertl, M. (2006) Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells. J Immunol 176, 3215-3222.
50. Ono, M., Shimizu, J., Miyachi, Y., and Sakaguchi, S. (2006) Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells. J Immunol 176, 4748-4756.
51. Krupnick, A.S., Gelman, A.E., Barchet, W., Richardson, S., Kreisel, F.H., Turka, L.A., Colonna, M., Patterson, G.A., and Kreisel, D. (2005) Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J Immunol 175, 6265-6270.
52. Grimbert, P., Bouguermouh, S., Baba, N., Nakajima, T., Allakhverdi, Z., Braun, D., Saito, H., Rubio, M., Delespesse, G., and Sarfati, M. (2006) Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells from human CD4+ CD25- T cells in response to inflammation. J Immunol 177, 3534-3541.
53. Gavin, M., and Rudensky, A. (2003) Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Curr Opin Immunol 15, 690-696.
54. Every, A.L., Kramer, D.R., Mannering, S.I., Lew, A.M., and Harrison, L.C. (2006) Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes. J Immunol 176, 4608-4615.
55. Chen, X., Murakami, T., Oppenheim, J.J., and Howard, O.M. (2004) Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur J Immunol 34, 859-869.
56. Zhan, Y., Funda, D.P., Every, A.L., Fundova, P., Purton, J.F., Liddicoat, D.R., Cole, T.J., Godfrey, D.I., Brady, J.L., Mannering, S.I., Harrison, L.C., and Lew, A.M. (2004) TCR-mediated activation promotes GITR upregulation in T cells and resistance to glucocorticoid-induced death. Int Immunol 16, 1315-1321.
57. Nardelli, B., Zaritskaya, L., McAuliffe, W., Ni, Y., Lincoln, C., Cho, Y.H., Birse, C.E., Halpern, W., Ullrich, S., and Moore, P.A. (2006) Osteostat/tumor necrosis factor superfamily 18 inhibits osteoclastogenesis and is selectively expressed by vascular endothelial cells. Endocrinology 147, 70-78.
58. Mahesh, S.P., Li, Z., Liu, B., Fariss, R.N., and Nussenblatt, R.B. (2006) Expression of GITR ligand abrogates immunosuppressive function of ocular tissue and differentially modulates inflammatory cytokines and chemokines. Eur J Immunol 36, 2128-2138.
59. Cardona, I.D., Goleva, E., Ou, L.S., and Leung, D.Y. (2006) Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. J Allergy Clin Immunol 117, 688-695.
60. Suvas, S., Kim, B., Sarangi, P.P., Tone, M., Waldmann, H., and Rouse, B.T. (2005) In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology. J Virol 79, 11935-11942.
61. Cuzzocrea, S., Nocentini, G., Di Paola, R., Mazzon, E., Ronchetti, S., Genovese, T., Muia, C., Caputi, A.P., and Riccardi, C. (2004) Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock. Journal of Leukocyte Biology 76, 933-940.
62. Lee, H.S., Shin, H.H., Kwon, B.S., and Choi, H.S. (2003) Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) increased MMP-9 activity in murine macrophage. J Cell Biochem 88, 1048-1056.
63. Cuzzocrea, S., Ronchetti, S., Genovese, T., Mazzon, E., Agostini, M., Di Paola, R., Esposito, E., Muia, C., Nocentini, G., and Riccardi, C. (2007) Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation. Faseb J. 21, 117-129.
64. Clark, R.A., and Kupper, T.S. (2007) IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood 109, 194-202.
65. Cuzzocrea, S., Ayroldi, E., Di Paola, R., Agostini, M., Mazzon, E., Bruscoli, S., Genovese, T., Ronchetti, S., Caputi, A.P., and Riccardi, C. (2005) Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis. Faseb J 19, 1253-1265.
66. Patel, M., Xu, D., Kewin, P., Choo-Kang, B., McSharry, C., Thomson, N.C., and Liew, F.Y. (2005) Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis. Eur J Immunol 35, 3581-3590.
67. Mottonen, M., Heikkinen, J., Mustonen, L., Isomaki, P., Luukkainen, R., and Lassila, O. (2005) CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 140, 360-367.
68. Morris, G.P., and Kong, Y.C. (2006) Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody. J Autoimmun 26, 24-31.
69. Gruss, H.J., and Dower, S.K. (1995) The TNF ligand superfamily and its relevance for human diseases. Cytokines and Molecular Therapy 1, 75-105.
70. Dittmer, U., He, H., Messer, R.J., Schimmer, S., Olbrich, A.R., Ohlen, C., Greenberg, P.D., Stromnes, I.M., Iwashiro, M., Sakaguchi, S., Evans, L.H., Peterson, K.E., Yang, G., and Hasenkrug, K.J. (2004) Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 20, 293-303.
71. La, S., Kim, E., and Kwon, B. (2005) In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1. Exp Mol Med 37, 193-198.
72. Smith, C.A., Farrah, T., and Goodwin, R.G. (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959-962.
73. Shin, H.H., Kim, S.J., Lee, H.S., and Choi, H.S. (2004) The soluble glucocorticoid-induced tumor necrosis factor receptor causes cell cycle arrest and apoptosis in murine macrophages. Biochem Biophys Res Commun 316, 24-32.
74. Yang, L., Froio, R.M., Sciuto, T.E., Dvorak, A.M., Alon, R., and Luscinskas, F.W. (2005) ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood 106, 584-592.
75. Cuzzocrea, S., and Reiter, R.J. (2001) Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. European Journal of Pharmacology 426, 1-10.
76. Vane, J.R., and Botting, R.M. (1995) New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 44, 1-10.
77. Shin, H.H., Kim, S.J., Kang, S.Y., Lee, D.S., and Choi, H.S. (2006) Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells. Bone 39, 716-723.
78. Shin, H.H., Lee, H.W., and Choi, H.S. (2003) Induction of nitric oxide synthase (NOS) by soluble glucocorticoid induced tumor necrosis factor receptor (sGITR) is modulated by IFN-gamma in murine macrophage. Exp Mol Med 35, 175-180.
79. Shin, H.H., Lee, M.H., Kim, S.G., Lee, Y.H., Kwon, B.S., and Choi, H.S. (2002) Recombinant glucocorticoid induced tumor necrosis factor receptor (rGITR) induces NOS in murine macrophage. FEBS Lett 514, 275-280.
80. Kim, W.J., Bae, E.M., Kang, Y.J., Bae, H.U., Hong, S.H., Lee, J.Y., Park, J.E., Kwon, B.S., Suk, K., and Lee, W.H. (2006) Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques. Immunology 119, 421-429.
81. Kim, S.J., Shin, H.H., Park, S.Y., Lee, D.S., Lee, E.A., Cho, S.D., Cho, H.R., Miyazawa, K., and Choi, H.S. (2006) Induction of MMP-13 expression by soluble human glucocorticoid-induced tumor necrosis factor receptor in fibroblast-like synovial cells. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 14, 146-153.
82. Schaub, B., Campo, M., He, H., Perkins, D., Gillman, M.W., Gold, D.R., Weiss, S., Lieberman, E., and Finn, P.W. (2006) Neonatal immune responses to TLR2 stimulation: influence of maternal atopy on Foxp3 and IL-10 expression. Respir. Res. 7, 40.
83. Esparza, E.M., and Arch, R.H. (2005) Glucocorticoid-induced TNF receptor functions as a costimulatory receptor that promotes survival in early phases of T cell activation. J Immunol 174, 7869-7874.
84. Kohm, A.P., Podojil, J.R., Williams, J.S., McMahon, J.S., and Miller, S.D. (2005) CD28 regulates glucocorticoidinduced TNF receptor family-related gene expression on CD4+ T cells via IL-2-dependent mechanisms. Cell Immunol 235, 56-64.
85. Kim, J., Choi, W.S., Kang, H., Kim, H.J., Suh, J.H., Sakaguchi, S., and Kwon, B. (2006) Conversion of alloantigen-specific CD8+ T cell anergy to CD8+ T cell priming through in vivo ligation of glucocorticoid-induced TNF receptor. J Immunol 176, 5223-5231.
86. Muriglan, S.J., Ramirez-Montagut, T., Alpdogan, O., Van Huystee, T.W., Eng, J.M., Hubbard, V.M., Kochman, A.A., Tjoe, K.H., Riccardi, C., Pandolfi, P.P., Sakaguchi, S., Houghton, A.N., and Van Den Brink, M.R. (2004) GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease. The Journal of Experimental Medicine 200, 149-157.
87. Shimizu, J., and Moriizumi, E. (2003) CD4+CD25- T cells in aged mice are hyporesponsive and exhibit suppressive activity. J Immunol 170, 1675-1682.
88. Tsaknaridis, L., Spencer, L., Culbertson, N., Hicks, K., LaTocha, D., Chou, Y.K., Whitham, R.H., Bakke, A., Jones, R.E., Offner, H., Bourdette, D.N., and Vandenbark, A.A. (2003) Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 74, 296-308.
89. La Cava, A., Ebling, F.M., and Hahn, B.H. (2004) Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J Immunol 173, 3542-3548.
90. Valzasina, B., Guiducci, C., Dislich, H., Killeen, N., Weinberg, A.D., and Colombo, M.P. (2005) Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood 105, 2845-2851.
91. Gondek, D.C., Lu, L.F., Quezada, S.A., Sakaguchi, S., and Noelle, R.J. (2005) Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 174, 1783-1786.
92. Ramirez-Montagut, T., Chow, A., Hirschhorn-Cymerman, D., Terwey, T.H., Kochman, A.A., Lu, S., Miles, R.C., Sakaguchi, S., Houghton, A.N., and van den Brink, M.R. (2006) Glucocorticoid-Induced TNF Receptor Family Related Gene Activation Overcomes Tolerance/Ignorance to Melanoma Differentiation Antigens and Enhances Antitumor Immunity. J Immunol 176, 6434-6442.
93. Ko, K., Yamazaki, S., Nakamura, K., Nishioka, T., Hirota, K., Yamaguchi, T., Shimizu, J., Nomura, T., Chiba, T., and Sakaguchi, S. (2005) Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. The Journal of Experimental Medicine 202, 885-891.
94. He, H., Messer, R.J., Sakaguchi, S., Yang, G., Robertson, S.J., and Hasenkrug, K.J. (2004) Reduction of retrovirusinduced immunosuppression by in vivo modulation of T cells during acute infection. J Virol 78, 11641-11647.
95. Agostini, M., Cenci, E., Pericolini, E., Nocentini, G., Bistoni, G., Vecchiarelli, A., and Riccardi, C. (2005) The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection. Infect Immun 73, 7502-7508.
96. Nocentini, G., Bartoli, A., Ronchetti, S., Giunchi, L., Cupelli, A., Delfino, D., Migliorati, G., and Riccardi, C. (2000) Gene structure and chromosomal assignment of mouse GITR, a member of the tumor necrosis factor/nerve growth factor receptor family. DNA Cell Biol 19, 205-217.
97. Banner, D.W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.J., Broger, C., Loetscher, H., and Lesslauer, W. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73, 431-445.
98. Jones, M.D., Hunt, J., Liu, J.L., Patterson, S.D., Kohno, T., and Lu, H.S. (1997) Determination of tumor necrosis factor binding protein disulfide structure: deviation of the fourth domain structure from the TNFR/NGFR family cysteine-rich region signature. Biochemistry 36, 14914-14923.
99. Orlinick, J.R., Vaishnaw, A., Elkon, K.B., and Chao, M.V. (1997) Requirement of cysteine-rich repeats of the Fas receptor for binding by the Fas ligand. The Journal of Biological Chemistry 272, 28889-28894.
100. Welcher, A.A., Bitler, C.M., Radeke, M.J., and Shooter, E.M. (1991) Nerve growth factor binding domain of the nerve growth factor receptor. Proceedings of the National Academy of Sciences of the United States of America 88, 159-163.
101. Spinicelli, S., Nocentini, G., Ronchetti, S., Krausz, L.T., Bianchini, R., and Riccardi, C. (2002) GITR interacts with the pro-apoptotic protein Siva and induces apoptosis. Cell Death Differ 9, 1382-1384.
102. Lotz, M., Setareh, M., von Kempis, J., and Schwarz, H. (1996) The nerve growth factor/tumor necrosis factor receptor family. Journal of Leukocyte Biology 60, 1-7.
103. Screaton, G.R., Xu, X.N., Olsen, A.L., Cowper, A.E., Tan, R., McMichael, A.J., and Bell, J.I. (1997) LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proceedings of the National Academy of Sciences of the United States of America 94, 4615-4619.
104. Nocentini, G., Ronchetti, S., Bartoli, A., Spinicelli, S., Delfino, D., Brunetti, L., Migliorati, G., and Riccardi, C. (2000) Identification of three novel mRNA splice variants of GITR. Cell Death Differ. 7, 408-410.
105. Hauer, J., Puschner, S., Ramakrishnan, P., Simon, U., Bongers, M., Federle, C., and Engelmann, H. (2005) TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Proceedings of the National Academy of Sciences of the United States of America 102, 2874-2879.
106. Park, Y.C., Burkitt, V., Villa, A.R., Tong, L., and Wu, H. (1999) Structural basis for self-association and receptor recognition of human TRAF2. Nature 398, 533-538.
107. Ye, H., Arron, J.R., Lamothe, B., Cirilli, M., Kobayashi, T., Shevde, N.K., Segal, D., Dzivenu, O.K., Vologodskaia, M., Yim, M., Du, K., Singh, S., Pike, J.W., Darnay, B.G., Choi, Y., and Wu, H. (2002) Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418, 443-447.
108. Esparza, E.M., and Arch, R.H. (2005) Glucocorticoid-induced TNF receptor, a costimulatory receptor on naive and activated T cells, uses TNF receptor-associated factor 2 in a novel fashion as an inhibitor of NF-kappa B activation. J. Immunol. 174, 7875-7882.
109. Esparza, E.M., Lindsten, T., Stockhausen, J.M., and Arch, R.H. (2006) Tumor necrosis factor receptor (TNFR)-associated factor 5 is a critical intermediate of costimulatory signaling pathways triggered by glucocorticoid-induced TNFR in T cells. The Journal of Biological Chemistry 281, 8559-8564.
110. Prasad, K.V., Ao, Z., Yoon, Y., Wu, M.X., Rizk, M., Jacquot, S., and Schlossman, S.F. (1997) CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proceedings of the National Academy of Sciences of the United States of America 94, 6346-6351.
111. Py, B., Slomianny, C., Auberger, P., Petit, P.X., and Benichou, S. (2004) Siva-1 and an alternative splice form lacking the death domain, Siva-2, similarly induce apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway. J Immunol 172, 4008-4017.
112. Lu, L.F., Gondek, D.C., Scott, Z.A., and Noelle, R.J. (2005) NF kappa B-inducing kinase deficiency results in the development of a subset of regulatory T cells, which shows a hyperproliferative activity upon glucocorticoid-induced TNF receptor family-related gene stimulation. J Immunol 175, 1651-1657.
113. Ramakrishnan, P., Wang, W., and Wallach, D. (2004) Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. Immunity 21, 477-489.
114. Dejardin, E. (2006) The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochemical pharmacology 72, 1161-1179.
115. Gudi, R., Barkinge, J., Hawkins, S., Chu, F., Manicassamy, S., Sun, Z., Duke-Cohan, J.S., and Prasad, K.V. (2006) Siva-1 negatively regulates NF-kappaB activity: effect on T-cell receptor-mediated activation-induced cell death (AICD). Oncogene 25, 3458-3462.
116. Tirone, F. (2001) The gene PC3 (TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? Journal of Cellular Physiology 187, 155-165.
117. Lin, W.J., Gary, J.D., Yang, M.C., Clarke, S., and Herschman, H.R. (1996) The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. The Journal of Biological Chemistry 271, 15034-15044.
118. An, W., Kim, J., and Roeder, R.G. (2004) Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 117, 735-748.
119. Berthet, C., Guehenneux, F., Revol, V., Samarut, C., Lukaszewicz, A., Dehay, C., Dumontet, C., Magaud, J.P., and Rouault, J.P. (2002) Interaction of PRMT1 with BTG/TOB proteins in cell signalling: molecular analysis and functional aspects. Genes Cells 7, 29-39.
120. Herrmann, F., Lee, J., Bedford, M.T., and Fackelmayer, F.O. (2005) Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo. The Journal of Biological Chemistry 280, 38005-38010.
121. Mowen, K.A., Schurter, B.T., Fathman, J.W., David, M., and Glimcher, L.H. (2004) Arginine methylation of NIP45 modulates cytokine gene expression in effector T lymphocytes. Molecular cell 15, 559-571.
122. Ganesh, L., Yoshimoto, T., Moorthy, N.C., Akahata, W., Boehm, M., Nabel, E.G., and Nabel, G.J. (2006) Protein methyltransferase 2 inhibits NF-kappa B function and promotes apoptosis. Molecular and Cellular Biology 26, 3864-3874.
123. Osanai, T., Saitoh, M., Sasaki, S., Tomita, H., Matsunaga, T., and Okumura, K. (2003) Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells. Hypertension 42, 985-990.
124. Lieberson, R., Mowen, K.A., McBride, K.D., Leautaud, V., Zhang, X., Suh, W.K., Wu, L., and Glimcher, L.H. (2001) Tumor necrosis factor receptor-associated factor (TRAF) 2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45). The Journal of Experimental Medicine 194, 89-98.
125. So, T., Salek-Ardakani, S., Nakano, H., Ware, C.F., and Croft, M. (2004) TNF receptor-associated factor 5 limits the induction of Th2 immune responses. J Immunol 172, 4292-4297.